Coverage: all available years, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Your saved research and appointment questionsView recorded trial and retraction changes
Tyrosinaemia Type III — Research Summary
Printed from RareWays (rareways.org) on 26 September 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
A rare coexistence: tyrosinemia type III and Wolff-Parkinson-White syndrome.
Yılmaz-Gümüş Emel et al. — Journal of pediatric endocrinology & metabolism : JPEM (24 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41956115/
- 2.
Different Clinic, Different Diagnosis: Tyrosinemia Type 3.
Basan Hacer et al. — Molecular syndromology (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41064053/
- 3.
Coexistence of phenylketonuria and tyrosinemia type 3: challenges in the dietary management.
Selamioğlu Arzu et al. — Journal of pediatric endocrinology & metabolism : JPEM (26 March 2025)
https://pubmed.ncbi.nlm.nih.gov/39787322/
- 4.
Novel HPD mutation p.A244V compound with p.T219M causing tyrosinemia type III in a Chinese girl and review of the genotype-phenotype spectrum.
Han Dong et al. — Molecular genetics & genomic medicine (1 January 2024)
https://pubmed.ncbi.nlm.nih.gov/37817461/
- 5.
Novel Cranial Imaging Findings and a Splice-Site Variant in a Patient with Tyrosinemia Type III, and a Summary of Published Cases.
Kahraman Ayca Burcu et al. — Molecular syndromology (1 May 2022)
https://pubmed.ncbi.nlm.nih.gov/35707594/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Tyrosinaemia Type III
Tyrosinaemia type III is a very rare inherited disorder in which the enzyme 4-hydroxyphenylpyruvate dioxygenase does not work properly, so the amino acid tyrosine builds up in the blood. Some children have intellectual disability, unsteady movement or seizures, while others have few symptoms. It is managed with a diet low in tyrosine and phenylalanine, with regular monitoring.
Tyrosinaemia Type III is very rare and little research has been published, so this page includes research from every year, including case reports about individual patients. Case reports are marked, and describe one person's experience rather than tested results.
Most Recent Research
OBJECTIVES: Tyrosinemia type III is an extremely rare autosomal recessive disorder of tyrosine metabolism caused by mutations in the HPD gene, which encodes 4-hydroxyphenylpyruvate dioxygenase (HPPD). Wolff-Parkinson-White (WPW) syndrome is a congenital cardiac conduction disorder characterized by the presence of an accessory atrioventricular pathway. While each condition is rare in isolation, their coexistence has not been previously reported. CASE PRESENTATION: We present a unique case of a 6-year-old boy with known WPW syndrome who was admitted with ketotic hypoglycemia after prolonged fasting and omission of propranolol doses. Metabolic work-up revealed persistently elevated plasma tyrosine levels. Genetic testing confirmed tyrosinemia type III due to a novel homozygous HPD variant [c.559A>G (p.Asn187Asp)]. The persistence of the WPW pattern despite decreased plasma tyrosine levels suggests that there is no direct causal relationship. He was also diagnosed with attention-deficit/hyperactivity disorder, specific learning disorder, and borderline intellectual functioning. CONCLUSIONS: This case highlights the importance of metabolic evaluation in pediatric patients presenting with unexplained hypoglycemia, particularly in the presence of pre-existing cardiac disorders.
Common Questions
What is Tyrosinaemia Type III?
Tyrosinaemia type III is a very rare inherited disorder in which the enzyme 4-hydroxyphenylpyruvate dioxygenase does not work properly, so the amino acid tyrosine builds up in the blood. Some children have intellectual disability, unsteady movement or seizures, while others have few symptoms. It is managed with a diet low in tyrosine and phenylalanine, with regular monitoring.
How many clinical trials are available for Tyrosinaemia Type III?
No clinical trials are currently indexed for Tyrosinaemia Type III. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Tyrosinaemia Type III come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Tyrosinaemia Type III.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.